1. Introduction {#s1}
===============

Heart failure (HF) is a major burden on healthcare systems worldwide. Approximately 1% of population are living with heart failure, and heart failure accounts for 1% of all primary diagnoses that result in hospital admission.[@b1] The prevalence of heart failure showed an increasing trend even though the prevalence of many cardiovascular diseases showed a decreasing trend due to the increased in aging population.[@b2]--[@b4] The rate of patient death among patients with HF is still very high. In-hospital mortality is estimated to be approximately 7%--10%, with one-year and five-year mortality rates of approximately 10% and 30%, respectively, in both Western and Asian populations.[@b5]--[@b7] Previous studies reported the differences in clinical presentation and outcomes of patients with heart failure when compared between Asian and Western populations.[@b8],[@b9] As such, the nature and clinical course of heart failure may differ between Asian and Western populations. Data from the Acute Decompensated Heart Failure National Registry (ADHERE) revealed that Asian patients hospitalized due to heart failure were approximately ten years younger earlier than Western patients, and that the disease is more severe in Asians than in Westerners.[@b10],[@b11] Moreover, the outcome of heart failure was reported to be poorer in elderly patients than in non-elderly patients.[@b8],[@b9],[@b12] This may, in part, be related to more advanced disease and/or suboptimal treatment relative to the treatment guidelines recommended for this group.[@b9],[@b13] However, the data of characteristics and outcomes of elderly population is scarce in developing countries.

The aim of this study was to investigate heart failure mortality after heart failure hospitalization compared between elderly and non-elderly Thai patients.

2. Methods {#s2}
==========

2.1. Study population {#s2a}
---------------------

This study included patients at least 18 years of age who were hospitalized to the hospital with a primary diagnosis of heart failure during 2008--2012 according to data from three major Thailand reimbursement systems \[Civil Servant Medical Benefit scheme (CS), Social Security scheme (SS), and Universal Coverage scheme (UC) systems\]. The diagnosis of heart failure was identified by using International Classifications of Disease, Tenth Edition, Thai Modification (ICD-10-TM code: 150.9). Among patients with more than one heart failure hospitalization, only the first hospitalization was included as the index admission. Patients were categorized into either the elderly group (age \> 65 years) or the non-elderly group (age ≤ 65 years). The protocol for this study was approved by the Siriraj Institutional Review Board (SIRB), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

2.2. Data collection {#s2b}
--------------------

Demographic, underlying disease and comorbid condition data were collected from inpatient medical expense claim data. Cardiovascular and non-cardiovascular death were also analyzed. Medical condition diagnosis data were searched and categorized by ICD-10-TM code. The ICD-10-TM codes were then grouped in the same manner as the Center of Medicare and Medicaid services (CMS) ICD-10-TM mapping.

Mortality data, including date and cause of death, was acquired from the Bureau of Registration Administration of Thailand.

2.3. Statistical analysis {#s2c}
-------------------------

All data analyses were performed using SPSS Statistics version 20.0 (SPSS, Inc., Chicago, IL, USA). Descriptive statistics were used to summarize demographic and clinical data. Continuous data are described using mean ± SD, and categorical data are shown using number and percentage. Continuous data were compared using Student\'s *t*-test for unpaired data, and categorical data were compared using chi-square test or Fisher\'s exact test. Univariate and multivariate Cox proportional hazards regression analysis was used to determine independent factors that predict death. Mortality rate and survival analysis was compared between elderly and non-elderly population. Kaplan-Meier analysis was used to demonstrate the mortality rate over time. Effect of elderly status on the main outcomes was tested using the interaction test of Cox regression analysis. The results of univariate and multivariate analysis are shown as unadjusted and adjusted hazard ratio (HR) and 95% confidence interval (CI). A *P*-value of less than 0.05 was considered statistically significant.

3. Results {#s3}
==========

There were a total of 201,709 patients admitted with a primary diagnosis of heart failure during 2008--2012 in Thailand. The average age was 64.9 ± 14.8 years, and 41.7% of patients were male. Just over half of patients (107,325 patients; 53.2%) were elderly (aged \> 65 years). Baseline characteristics of elderly and non-elderly patients are shown in [Table 1](#jgc-15-12-718-t01){ref-type="table"}. Elderly patients were found to be significantly more likely to have many cardiovascular risk factors and comorbid conditions than non-elderly patients except for diabetes and rheumatic heart disease. Mortality data was available for an average of 24.8 ± 20.6 months after the index admission. Among the 201,709 included patients, 102,407 (50.8%) died. Comparisons of baseline data between patients who died and patients who survived are shown in [Table 2](#jgc-15-12-718-t02){ref-type="table"}. Deceased patients are more likely to have comorbid conditions and/or risk factors compared to those who survived. Univariate and multivariate analysis for factors associated with increased risk of death are shown in [Table 3](#jgc-15-12-718-t03){ref-type="table"}. Multivariate analysis revealed elderly status to be the second strongest independent predictor of mortality following chronic kidney disease (CKD). Kaplan-Meier analysis of all-cause death for the whole group is shown in [Figure 1A](#jgc-15-12-718-g001){ref-type="fig"}. [Figure 1B](#jgc-15-12-718-g001){ref-type="fig"} shows that the elderly were significantly more likely to die early after heart failure hospitalization than non-elderly patients. Moreover, the curves diverge over time demonstrating the adverse effect of aging on mortality.

###### Baseline characteristics of elderly and non-elderly heart failure patients.

  Characteristics                     Total           Elderly        Non-elderly    *P*-value
  ------------------------------ ---------------- ---------------- --------------- -----------
  Patients                            201709       107325 (53.2%)   94384 (46.8%)  
   Age, yrs                        64.9 ± 14.8       76.2 ± 6.8      52.2 ± 10.4   
   Male gender                    84155 (41.7%)    41002 (38.2%)    43153 (45.7%)   \< 0.001
  Comorbid conditions                                                                  \-
   Prior heart failure            30583 (15.2%)    16670 (15.5%)    13913 (14.7%)   \< 0.001
   Prior myocardial infarction     14085 (7.0%)     8261 (7.7%)      5827 (6.2%)    \< 0.001
   Non-rheumatic VHD              20199 (10.0%)     9609 (9.0%)     10590 (11.2%)   \< 0.001
   Rheumatic heart disease         12850 (6.4%)     4381 (4.1%)      8469 (9.0%)    \< 0.001
   Ischemic stroke                 7117 (3.5%)      4110 (3.8%)      3007 (3.2%)    \< 0.001
   Peripheral vascular disease      924 (0.5%)       667 (0.6%)      257 (0.3%)     \< 0.001
   Hypertension                   106601 (52.8%)   62016 (57.8%)    44585 (47.2%)   \< 0.001
   Diabetes mellitus              63520 (31.5%)    31210 (29.1%)    32310 (34.2%)   \< 0.001
   Dyslipidemia                   47248 (23.4%)    25693 (23.9%)    21555 (22.8%)   \< 0.001
   Chronic kidney disease         57700 (28.6%)    32678 (30.4%)    25022 (26.5%)   \< 0.001

Data are presented as means ± SD or *n* (%), a *P*-value \< 0.05 indicates statistical significance. VHD: valvular heart disease.

###### Baseline characteristics compared between patients who died and patients who survived during the follow-up.

  Characteristics                   Deceased        Survived      *P*-value
  ------------------------------ --------------- --------------- -----------
  Elderly status (\> 65 yrs)      61933 (57.7%)   45392 (42.3%)   \< 0.001
  Male gender                     44585 (53.0%)   39570 (47.0%)   \< 0.001
  Comorbid conditions                                            
   Prior heart failure            19355 (63.3%)   11228 (36.7%)   \< 0.001
   Prior myocardial infarction    8522 (60.5%)    5563 (39.5%)    \< 0.001
   Non-rheumatic VHD              10767 (53.3%)   9432 (46.7%)    \< 0.001
   Rheumatic heart disease        6559 (51.0%)    6291 (49.0%)    \< 0.001
   Ischemic stroke                4305 (60.5%)    2812 (39.5%)    \< 0.001
   Peripheral vascular disease     604 (65.4%)     320 (34.6%)    \< 0.001
   Hypertension                   54192 (50.8%)   52409 (49.2%)     0.526
   Diabetes mellitus              34375 (54.1%)   29145 (45.9%)   \< 0.001
   Dyslipidemia                   21866 (46.3%)   25382 (53.7%)   \< 0.001
   Chronic kidney disease         37937 (65.7%)   19763 (34.3%)   \< 0.001

Data are presented as means ± SD or *n* (%), a *P*-value \< 0.05 indicates statistical significance. VHD: valvular heart disease.

###### Univariate and multivariate analysis for factors associated with increased mortality in Thai heart failure patients.

  Factors                         Unadjusted HR (95% CI)   *P*-value   Adjusted HR (95% CI)   *P*-value
  ------------------------------ ------------------------ ----------- ---------------------- -----------
  Elderly status (\> 65 yrs)        1.51 (1.49--1.53)      \< 0.001     1.48 (1.46--1.49)     \< 0.001
  Male gender                       1.12 (1.11--1.14)      \< 0.001     1.12 (1.11--1.14)     \< 0.001
  Comorbid conditions                                                                        
   Prior heart failure              1.43 (1.41--1.45)      \< 0.001     1.27 (1.25--1.30)     \< 0.001
   Prior myocardial infarction      1.34 (1.31--1.37)      \< 0.001     1.03 (1.001--1.05)      0.044
   Non-rheumatic VHD                1.08 (1.05--1.09)      \< 0.001      1.10 (1.08-1.12)     \< 0.001
   Rheumatic heart disease          0.97 (0.95--0.99)        0.032              \-               \-
   Ischemic stroke                  1.35 (1.31--1.40)      \< 0.001     1.23 (1.19--1.27)     \< 0.001
   Peripheral vascular disease      1.50 (1.38--1.62)      \< 0.001     1.16 (1.07--1.26)     \< 0.001
   Hypertension                     1.01 (0.99--1.02)        0.191              \-               \-
   Diabetes mellitus                1.14 (1.12--1.15)      \< 0.001             \-               \-
   Dyslipidemia                     0.86 (0.85--0.87)      \< 0.001             \-               \-
   Chronic kidney disease           1.91 (1.89--1.94)      \< 0.001     1.82 (1.79--1.84)     \< 0.001

A *P*-value \< 0.05 indicates statistical significance. VHD: valvular heart disease.

![Kaplan-Meier analysis of all-cause death in the whole group (A), and compared between the elderly and non-elderly (B).](jgc-15-12-718-g001){#jgc-15-12-718-g001}

Cause of death data was available only in the 186,062 (92.2%) patients covered by the UC reimbursement system. Among those patients, 97,147 (52.2%) patients died. Analysis of cause of death was based on the available data.[Table 4](#jgc-15-12-718-t04){ref-type="table"} shows cause of death compared between cardiovascular and non-cardiovascular causes in both the elderly and non-elderly groups. Cardiovascular death was observed in 52,534 patients accounting 54.1% of all death. [Table 5](#jgc-15-12-718-t05){ref-type="table"} shows the rate of all-cause death, cardiovascular death, and non-cardiovascular death at one-month, six-months, one-year, and three-years. Elderly patients had an increased risk of death compared to non-elderly patients. Elderly status had an impact on non-cardiovascular death more than cardiovascular death. [Table 6](#jgc-15-12-718-t06){ref-type="table"} shows univariate and multivariate analysis of elderly status as a predicting factor for increased all-cause, cardiovascular, and non-cardiovascular mortality. After adjusting for potential confounders, elderly status was found to be an independent predictor of both cardiovascular and non-cardiovascular death. The hazard ratio for elderly status resulting in non-cardiovascular death is greater than the hazard ratio for elderly status resulting in cardiovascular death. [Figure 2](#jgc-15-12-718-g002){ref-type="fig"} shows Kaplan-Meier analysis of cardiovascular death and non-cardiovascular death in the whole group ([Figure 2A](#jgc-15-12-718-g002){ref-type="fig"}), and compared between the elderly and non-elderly groups ([Figure 2B](#jgc-15-12-718-g002){ref-type="fig"}). Similar to [Figure 1](#jgc-15-12-718-g001){ref-type="fig"}, the curves in [Figure 2B](#jgc-15-12-718-g002){ref-type="fig"} show an increased disparity in the death rate over time between elderly and non-elderly patients, which reflects the persistent effect of elderly status on mortality.

###### Causes of death among 186,062 Thai heart failure patients.

  Cause of death               *n*    Percent of the whole group\* (*n* = 186062)   Percent of those who died (*n* = 97147)   Percent among the elderly (*n* = 102100)   Percent among the non-elderly (*n* = 83962)
  -------------------------- ------- --------------------------------------------- ----------------------------------------- ------------------------------------------ ---------------------------------------------
  Bold                        52534                     28.23%                                      54.08%                                     51.45%                                      62.57%
  Heart failure               31621                     16.99%                                      32.55%                                     30.97%                                      37.66%
  Myocardial infarction       10500                      5.64%                                      10.81%                                     10.28%                                      12.51%
  Valvular heart disease      2306                       1.24%                                       2.37%                                     2.26%                                        2.75%
  Arrhythmia                  3424                       1.84%                                       3.52%                                     3.35%                                        4.08%
  Congenital heart disease     128                       0.07%                                       0.13%                                     0.13%                                        0.15%
  Stroke                      3222                       1.73%                                       3.32%                                     3.16%                                        3.84%
  Pulmonary embolism           180                       0.10%                                       0.19%                                     0.18%                                        0.21%
  Hypertensive emergency       670                       0.36%                                       0.69%                                     0.66%                                        0.80%
  Vascular disease             483                       0.26%                                       0.50%                                     0.47%                                        0.58%
  Bold                        44613                     23.98%                                      45.92%                                     43.70%                                      53.13%
  Sepsis                      4332                       2.33%                                       4.46%                                     4.24%                                        5.16%
  Pneumonia                   2718                       1.46%                                       2.80%                                     2.66%                                        3.24%
  Renal failure               6645                       3.57%                                       6.84%                                     6.51%                                        7.91%
  Cancer                      2207                       1.19%                                       2.27%                                     2.16%                                        2.63%
  Respiratory failure         1191                       0.64%                                       1.23%                                     1.17%                                        1.42%
  Bleeding                     769                       0.41%                                       0.79%                                     0.75%                                        0.92%
  Accident                     255                       0.14%                                       0.26%                                     0.25%                                        0.30%
  Diabetic complication       2468                       1.33%                                       2.54%                                     2.42%                                        2.94%
  Cirrhosis                    648                       0.35%                                       0.67%                                     0.63%                                        0.77%
  COPD/asthma                 1773                       0.95%                                       1.83%                                     1.74%                                        2.11%
  Senility                    11875                      6.38%                                      12.22%                                     11.63%                                      14.14%
  Others                      9732                       5.23%                                      10.02%                                     9.53%                                       11.59%

Data are presented as means ± SD or *n* (%), \*Cause of death data was available only in patients in the universal coverage reimbursement system (*n* = 186062). COPD: chronic obstructive pulmonary disease.

###### All-cause, cardiovascular, and non-cardiovascular death at one month, six months, one year, and three years.

                                Cumulative event rate                                                  
  ---------------------------- ----------------------- --------------- --------------- --------------- ---------------
  All-cause death                                                                                      
   All                                 201709           22175 (11.0%)   49457 (24.5%)   65493 (32.5%)   93437 (46.3%)
   Age \> 65 yrs                       107325           13029 (12.1%)   29662 (27.6%)   39274 (36.6%)   56515 (52.7%)
   Age ≤ 65 yrs                         94384            9146 (9.7%)    19795 (21.0%)   26219 (27.8%)   36922 (39.1%)
  Cardiovascular death\*                                                                               
   All                                 186062           11339 (6.1%)    24584 (13.2%)   33014 (17.7%)   47757 (25.7%)
   Age \> 65 yrs                       102100            6350 (6.2%)    14067 (13.8%)   18894 (18.5%)   27558 (27.0%)
   Age ≤ 65 yrs                         83962            4989 (5.9%)    10517 (12.5%)   14120 (16.8%)   20199 (24.1%)
  Non-cardiovascular death\*                                                                           
   All                                 186062            9915 (5.3%)    22739 (12.2%)   29552 (15.9%)   41834 (22.5%)
   Age \> 65 yrs                       102100            6353 (6.2%)    14808 (14.5%)   19238 (18.8%)   27513 (27.0%)
   Age ≤ 65 yrs                         83962            3562 (4.2%)     7931 (9.4%)    10314 (12.3%)   14321 (17.1%)

Data are presented as means ± SD or *n* (%), \*Cause of death data was available only in patients in the universal coverage reimbursement system (*n* = 186062).

###### Univariate and multivariate analysis of elderly status as a predicting factor for increased all-cause, cardiovascular, and non-cardiovascular mortality.

  Factors                     Unadjusted HR (95% CI)   *P*-value   Adjusted HR (95% CI)   *P*-value
  -------------------------- ------------------------ ----------- ---------------------- -----------
  All-cause death               1.51 (1.49--1.53)      \< 0.001     1.47 (1.46--1.49)     \< 0.001
  Cardiovascular death          1.25 (1.23--1.27)      \< 0.001     1.25 (1.23--1.27)     \< 0.001
  Non-cardiovascular death      1.78 (1.75--1.82)      \< 0.001     1.72 (1.68--1.75)     \< 0.001

A *P*-value \< 0.05 indicates statistical significance.
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4. Discussion {#s4}
=============

In this study of 2008--2012 Thailand national claim data in patients admitted with heart failure as the primary diagnosis, we found a mortality rate of 11.0% at one month, 24.5% at six months, 32.5% at one year, and 46.3% at three years. After CKD, old age (age \> 65 years) was identified as the most important factor determining mortality after hospitalization for heart failure.

Despite the advances in medications and device therapy for heart failure, the mortality rate in patients with heart failure remains high. Overall mortality during heart failure hospitalization and at one year was 7%--10% and 30%,[@b1],[@b14],[@b15] respectively, among several reports from the United States,[@b11] Europe,[@b16],[@b17] and Asia-Pacific countries.[@b10] In addition, heart failure outcomes may vary among geographic regions, which may reflect a disparity in access to healthcare, healthcare infrastructure, and other factors.[@b9],[@b18] The International Congestive Heart Failure (INTER-CHF) study revealed different mortality rates among Asian countries, which may be attributable to differences in healthcare systems, access to medication, and environmental factors.[@b8] The mortality rate in the present study is similar to the rates reported from previous studies.

Heart failure in the Asia-Pacific region presents at approximately ten years younger than the presentation age data reported from Western countries.[@b10],[@b11],[@b17] Moreover, patients with heart failure from Asia-Pacific countries tend to have more severe condition,[@b10] and they tend to receive suboptimal standard treatment including inadequate doses of medications and underutilization of implantable cardioverter defibrillator.[@b13] The prevalence of heart failure increases with age. It is estimated that 70% of the heart failure population that will increase in prevalence in the future will consist of those aged older than 65 years.[@b2] Previous data showed that the heart failure mortality rate is significantly higher in elderly population than in non-elderly population.[@b8],[@b19] In addition to our data demonstrating that the mortality rate higher in the elderly compared to the non-elderly group, we also found elderly status to be a factor that significantly predicts patient prognosis after heart failure hospitalization, with an HR and 95% CI of 1.48 and 1.46--1.49, respectively. The most significant factor that determines outcome of heart failure in the present study was chronic kidney disease. Other important factors identified in this study were male gender, prior heart failure hospitalization, prior myocardial infarction, valvular heart disease, ischemic stroke, and peripheral vascular disease.

Elderly status is associated with many risk factors and comorbid conditions that may increase the risk of death, including hypertension, diabetes, prior myocardial infarction, ischemic stroke, peripheral vascular disease, and CKD.[@b19] However, in our study and after adjusting for these factors in multivariate model, elderly status remained the second strongest independent factor affecting heart failure outcomes after CKD. In our study, the cause of death in patients with heart failure was cardiovascular-related in 54.1% of cases, and non-cardiovascular-related in 45.9% of cases. These proportions are similar to those described in previous reports,[@b8] although death from unknown causes accounted for a significant proportion of heart failure population in the INTER-CHF study.[@b8] Elderly status increases the risk of death from both cardiovascular and non-cardiovascular causes. The survival analysis curves representing the cumulative mortality rate between the elderly and non-elderly groups separates early after heart failure hospitalization, and then continues to progressively separate until the end of the follow-up, which reflects the importance and impact of elderly status on heart failure outcome.

4.1. Limitations {#s4a}
----------------

There are some mentionable limitations in this study. (1) we had no access to left ventricular ejection fraction (LVEF). Therefore, we were not able to compare elderly patients with heart failure with reduced ejection fraction (HFrEF) with patients with heart failure with preserved ejection fraction (HFpEF). However, a previous study reported no difference in patient prognosis compared between patients with HFrEF and patients with HFpEF.[@b20] (2) The presence of either HFrEF or HFpEF would not have impacted mortality in either of our two study groups. Second, we did not have access to medication or treatment data, so neither of those factors were included in our analysis. (3) Due to the nature of retrospective study using the routine collected database, there may be a limited accuracy in identifying heart failure and other comorbid conditions; and (4) the cause of death given in the death certificate may have a limited accuracy.

4.2. Conclusion {#s4b}
---------------

The overall mortality rate after heart failure hospitalization was a very high 50.8%. Multivariate analysis revealed elderly status to be an independent predictor of mortality after hospitalization. This finding suggests that improvements are needed relative to the quality of care and follow-up given to elderly heart failure patients.
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